Speaker:

Farouk Mookadam, M.D., M.B.B.Ch.

Teaching/Examining Privileges in Clinical & Translational Sci. - Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic College of Medicine and Science

Associate Program Director - Internal Medicine Residency Program, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona

Professor of Medicine - Mayo Clinic College of Medicine and Science

Co-Director - Cardio-Oncology Clinic, Divisions of Cardiovascular Diseases and Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona

Consultant - Department of Cardiovascular Diseases, Mayo Clinic, Scottsdale/Phoenix, Arizona

Objectives: 

• Identify patients that benefit from care in a specialized cardio-oncology program.
• Recognize cardiac effects of multimodality therapies in patients with Thoracic cancer
• Identify diagnostic, and management options in the care of thoracic cancer patients with cardiovascular illness.
• Summarize treatment strategies using a case-based approach.
• Demonstrate a multidisciplinary approach to cardio-oncology patients using current guideline recommendations from  ESC, ASE and ASCO

Locations:    

• Mayo Clinic Building, Taylor Auditorium
• Mayo Clinic Hospital, MCH Waugh Auditorium Side A and MH 1-212 (overflow)
• Mayo Clinic Primary Care, Phoenix Campus
• Mayo Clinic Women’s Health Internal Medicine
• Mayo Clinic Family Medicine – Arrowhead
• Kingman Regional Medical Center
• San Tan Medical Center
• Canyon Ranch Medical Center

ALL PHYSICIANS AND ALLIED STAFF ARE WELCOME

ATTENDANCE REQUIREMENT 
A unique presentation code must be sent via text to 507-200-3010 
to record attendance and to ensure you receive CME credit for your attendance.  
NOTE:  Attendees must be present to receive code.  

FACULTY DISCLOSURE

As a provider accredited by Accreditation Council on Continuing Medical Education (ACCME), Mayo Clinic College of Medicine and Science, must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships is included course materials so participants may formulate their own judgments regarding the presentation.